BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu S, Ma Z, Gu Y, Li P, Chen Y, Bai M, Zhou H, Yang X, Jiang H. Downregulation of glucose‐6‐phosphatase expression contributes to fluoxetine‐induced hepatic steatosis. J Appl Toxicol 2021;41:1232-40. [DOI: 10.1002/jat.4109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu S, Zhao J, Chen X, Xu S, Yang X, Zhang Y, Ma Z, Jiang H, Zhou H. Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation. Chemico-Biological Interactions 2022;368:110219. [DOI: 10.1016/j.cbi.2022.110219] [Reference Citation Analysis]
2 Chen M, Bai M, Yi Y, Lu S, Luo J, Li P, Zhang H, Jiang H, Zhou H. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice. Toxicol Lett 2022:S0378-4274(22)00091-1. [PMID: 35589016 DOI: 10.1016/j.toxlet.2022.05.003] [Reference Citation Analysis]
3 Ayyash A, Holloway AC. Fluoxetine-induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15-deoxy-Δ12,14 PGJ2. J Appl Toxicol 2021. [PMID: 34897744 DOI: 10.1002/jat.4272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ayyash A, Holloway AC. Fluoxetine-induced hepatic lipid accumulation is linked to elevated serotonin production. Can J Physiol Pharmacol 2021;99:983-8. [PMID: 33517848 DOI: 10.1139/cjpp-2020-0721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]